For October 2023, we have the Human Epidermal growth factor Receptor 3 (HER3) as the 'Clovertex Drug...
September's Clovertex Target of the Month is GPR61 following Pfizer's recent publication concerning ...
In August 2023, the GABAA receptor is highlighted our 'Clovertex Target of the Month' as the drug ta...
For July 2023, we focus our attention on the Adeno-Associated Virus serotype 9 (AAV9) as the 'Clover...
What if we told you that an automated RELION workflow could potentially outperform human users in si...
Following the previous discussions on IoT in Cryo-EM and the resurgence of the manual plunge cooler,...
For June 2023, we draw your attention to the Endothelin A Receptor (ETAR) as the 'Clovertex Drug Tar...
Whenever I hear about Internet of Things (IoT), I think of smart fridges that have been touted as th...
For May 2023, we're spotlighting the Glucagon-Like Peptide-2 Receptor (GLP2R) as the 'Clovertex Drug...
In the fast-paced world of cryo-EM methods, remarkable advancements can occasionally go unnoticed am...